Role Patient Blood Management Practitioner Employer NHSBT Email
The newsletters provide information on the outputs from the UK Cell Salvage Action Group (UKCSAG). The Winter 2023 edition is now available. Topics include cell salvage and SHOT, ant…
6.2: Setting and maintaining specifications The wide variability of the source material from which blood components are prepared makes it difficult to set stringent limits. Nevertheless,…
UKCSAG Newsletter - Winter 2023.pdf (188KB)
CN 03-2024 - Red Book Updates Batch 3 v1.pdf (2MB)
7.7.11: Cryoprecipitate for Neonates and Infants, Leucocyte Depleted The component represents a source of concentrated FVIII, and von Willebrand factor, fibrinogen, FXIII and fibronectin…
7.5.5: Cryoprecipitate, Pooled, Pathogen Reduced, Leucocyte Depleted The component provides a concentrated source of FVIII, and von Willebrand factor, fibrinogen, Factor XIII and fibrone…
7.5.2: Fresh Frozen Plasma, Pathogen Reduced, Leucocyte Depleted Fresh Frozen Plasma, Pathogen Reduced, Leucocyte Depleted, is plasma that has been obtained from whole blood or by aphere…
Blood Components for Contingency Use A5.2: Platelets, Apheresis, Leucocyte Depleted, at Reduced Dose as a Contingency A single-donor platelet compo…
Blood Components for Contingency Use A5.1: Red Cells in Additive Solution, Leucocyte Depleted, Extended…
Provisional Component A3.5: Red Cells and Plasma, Leucocyte Depleted A unit of blood collected into CPD anticoagulant, containing less than 1 &time…
Provisional Component A3.4: Red Cells, Rejuvenated and Washed, Leucocyte Depleted A red cell component, containing less than 1 × 106
Provisional Component A3.2: Red Cells in Additive Solution, Leucocyte Depleted, Pathogen Reduced A red cell component containing less than 1 ×…
Provisional Component A3.1: Platelets in Additive Solution and Plasma, Leucocyte Depleted, Pathogen Reduced A platelet concentrate, derived from bu…
7.7.12: Cryoprecipitate for Neonates and Infants, Pathogen Reduced, Leucocyte Depleted The component provides a source of concentrated FVIII, and von Willebrand factor, fibrino…
7.7.7: Platelets for Neonatal Use, Leucocyte Depleted An apheresis platelet component for neonatal use that contains less than 1 × 106 leucocytes per starting component.…
7.7.8: Platelets in Plasma and Additive Solution for Neonatal Use, Leucocyte Depleted An apheresis platelet component for neonatal use which contains less than 1 × 106 …
7.7.6: Platelets for Intrauterine Transfusion, Leucocyte Depleted A hyperconcentrated platelet component for intrauterine transfusion, prepared by apheresis, that contains less than 1&n…
7.7.5: Red Cells in Additive Solution for Neonates and Infants, Leucocyte Depleted A red cell component suitable for top-up or large-volume transfusion of neonates and infants under 1 y…
7.7.4: Red Cells for Neonates and Infants, Leucocyte Depleted A red cell component suitable for neonates and infants under 1 year that contains less than 1 × 106 leucoc…
7.7.2: Whole Blood for Exchange Transfusion, Leucocyte Depleted A component for exchange or large-volume transfusion of neonates, containing less than 1 × 106 leucocyte…
7.4.4: Platelets in Additive Solution, Leucocyte Depleted A platelet concentrate derived from buffy coats or apheresis, which contains less than 1 × 106 leucocytes and …
7.4.3: Platelets, Pooled, Buffy Coat Derived, in Additive Solution and Plasma, Leucocyte Depleted A platelet concentrate, derived from buffy coats, which contains less than 1 × 10…